$RLFTF DD Hooter on Yh0 Latest Relief response.
Post# of 653
Dear Mr. Hooter:
Like you, we are concerned about the COVID-19 situation in emerging markets. Once we obtain the full data set from the U.S. Ph. 2b/3 study, we intend to reach out to regulators in various markets to discuss options to bring RLF-100 to patients. This could include India.
Kind regards,
Relief Therapeutics